Justin S. Antony

1.1k total citations
33 papers, 669 citations indexed

About

Justin S. Antony is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Justin S. Antony has authored 33 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Genetics. Recurrent topics in Justin S. Antony's work include CRISPR and Genetic Engineering (14 papers), Virus-based gene therapy research (7 papers) and CAR-T cell therapy research (6 papers). Justin S. Antony is often cited by papers focused on CRISPR and Genetic Engineering (14 papers), Virus-based gene therapy research (7 papers) and CAR-T cell therapy research (6 papers). Justin S. Antony collaborates with scholars based in Germany, India and Republic of the Congo. Justin S. Antony's co-authors include Michael Kormann, Rupert Handgretinger, Markus Mezger, A.K.M. Ashiqul Haque, Richard I. Hogrefe, Sriram Vaidyanathan, Matthew H. Porteus, Anton P. McCaffrey, Ayal Hendel and Sabrina Shore and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Justin S. Antony

32 papers receiving 648 citations

Peers

Countries citing papers authored by Justin S. Antony

Since Specialization

Citations

This map shows the geographic impact of Justin S. Antony's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Justin S. Antony with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Justin S. Antony more than expected).

Fields of papers citing papers by Justin S. Antony

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Justin S. Antony. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Justin S. Antony. The network helps show where Justin S. Antony may publish in the future.

Co-authorship network of co-authors of Justin S. Antony

This figure shows the co-authorship network connecting the top 25 collaborators of Justin S. Antony. A scholar is included among the top collaborators of Justin S. Antony based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Justin S. Antony. Justin S. Antony is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The synergistic anti-Warburg efficacy of temozolomide, metformin and epigallocatechin gallate in glioblastoma 2024 ·Toxicology and Applied Pharmacology ·(unknown), (unknown), (unknown), Justin S. Antony, (unknown), (unknown)	2
2	Gene therapy in pediatrics – Clinical studies and approved drugs (as of 2023) 2024 ·Life Sciences ·(unknown), (unknown), (unknown), (unknown), Miso Kim, Justin S. Antony, Markus Mezger	4
3	A combination of metformin and epigallocatechin gallate potentiates glioma chemotherapy in vivo 2023 ·Frontiers in Pharmacology ·(unknown), (unknown), (unknown), (unknown), Arumugam Ramachandran Muralidharan, (unknown), Markus Mezger, Justin S. Antony, (unknown), Biswajit Dubashi, (unknown), Kanive Parashiva Guruprasad, (unknown)	11
4	CRISPR-Cas9-Based Gene Knockout of Immune Checkpoints in Expanded NK Cells 2023 ·International Journal of Molecular Sciences ·(unknown), Miso Kim, (unknown), (unknown), (unknown), (unknown), Fatemeh Zahedipour, (unknown), Justin S. Antony, Markus Mezger	9
5	CRISPR medicine for blood disorders: Progress and challenges in delivery 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), Justin S. Antony, Rupert Handgretinger, Markus Mezger	8
6	Somatic Reversion of a Novel IL2RG Mutation Resulting in Atypical X-Linked Combined Immunodeficiency 2021 ·Genes ·(unknown), (unknown), (unknown), (unknown), Karin Schilbach, (unknown), Derya Güngör, (unknown), Elke Malenke, Justin S. Antony, Rupert Handgretinger, Markus Mezger	8
7	A Mutation-Agnostic Hematopoietic Stem Cell Gene Therapy for Metachromatic Leukodystrophy 2021 ·The CRISPR Journal ·Justin S. Antony, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jun-Hoe Lee, Lukas Heumos, Judith Böhringer, Ingeborg Krägeloh‐Mann, Rupert Handgretinger, Markus Mezger	11
8	Universal Gene Correction Approaches for β-hemoglobinopathies Using CRISPR-Cas9 and Adeno-Associated Virus Serotype 6 Donor Templates 2021 ·The CRISPR Journal ·(unknown), (unknown), (unknown), (unknown), (unknown), Thomas Epting, Sabina Marciano, Lukas Heumos, Praveen Baskaran, Justin S. Antony, Rupert Handgretinger, Markus Mezger	6
9	Comparative targeting analysis of KLF1, BCL11A, and HBG1/2 in CD34+ HSPCs by CRISPR/Cas9 for the induction of fetal hemoglobin 2020 ·Scientific Reports ·(unknown), (unknown), Justin S. Antony, Thomas Epting, Lukas Heumos, Praveen Baskaran, Jakob Admard, Nicolas Casadei, (unknown), (unknown), Michael Kormann, Rupert Handgretinger, Markus Mezger	44
10	Comparative analysis of lentiviral gene transfer approaches designed to promote fetal hemoglobin production for the treatment of β-hemoglobinopathies 2020 ·Blood Cells Molecules and Diseases ·(unknown), (unknown), Andrew Wilber, Christopher B. Chambers, Ian Johnston, Justin S. Antony, Thomas Epting, Rupert Handgretinger, Markus Mezger	3
11	RNA ImmunoGenic Assay: A Method to Detect Immunogenicity of in vitro Transcribed mRNA in Human Whole Blood 2020 ·BIO-PROTOCOL ·A.K.M. Ashiqul Haque, (unknown), (unknown), Rupert Handgretinger, Markus Mezger, Michael Kormann, Justin S. Antony	3
12	CRISPR/Cas9-modified hematopoietic stem cells—present and future perspectives for stem cell transplantation 2019 ·Bone Marrow Transplantation ·(unknown), (unknown), (unknown), Justin S. Antony, Rupert Handgretinger, Markus Mezger	26
13	Gene correction of HBB mutations in CD34+ hematopoietic stem cells using Cas9 mRNA and ssODN donors 2018 ·PubMed ·Justin S. Antony, (unknown), A.K.M. Ashiqul Haque, (unknown), (unknown), (unknown), Praveen Baskaran, (unknown), Markus Mezger, Rupert Handgretinger, Michael Kormann	40
14	Chemically modified hCFTR mRNAs recuperate lung function in a mouse model of cystic fibrosis 2018 ·Scientific Reports ·A.K.M. Ashiqul Haque, Alexander Dewerth, Justin S. Antony, Joachim Riethmüller, (unknown), (unknown), (unknown), (unknown), Nicoletta Pedemonte, Elvira Sondo, (unknown), Anjali Ralhan, Julie Laval, Patrick Schlegel, Christian Seitz, Brigitta Loretz, Claus‐Michael Lehr, Rupert Handgretinger, Michael Kormann	64
15	Uridine Depletion and Chemical Modification Increase Cas9 mRNA Activity and Reduce Immunogenicity without HPLC Purification 2018 ·Molecular Therapy — Nucleic Acids ·Sriram Vaidyanathan, (unknown), A.K.M. Ashiqul Haque, Jordana M. Henderson, Ayal Hendel, Sabrina Shore, Justin S. Antony, Richard I. Hogrefe, Michael Kormann, Matthew H. Porteus, Anton P. McCaffrey	192
16	Transcriptomic profile of cystic fibrosis patients identifies type I interferon response and ribosomal stalk proteins as potential modifiers of disease severity 2017 ·PLoS ONE ·Michael Kormann, Alexander Dewerth, (unknown), Praveen Baskaran, Andreas Hector, Nicolas Regamey, Dominik Hartl, Rupert Handgretinger, Justin S. Antony	22
17	Lectin Complement Protein Collectin 11 (CL-K1) and Susceptibility to Urinary Schistosomiasis 2015 ·PLoS neglected tropical diseases ·Justin S. Antony, Olusola Ojurongbe, Peter G. Kremsner, Thirumalaisamy P. Velavan	14
18	Mannose-binding Lectin (MBL) as a susceptible host factor influencing Indian Visceral Leishmaniasis 2015 ·Parasitology International ·Anshuman Mishra, Justin S. Antony, (unknown), (unknown), Hoang Văn Tong, (unknown), Lalji Singh, Thirumalaisamy P. Velavan, Kumarasamy Thangaraj	8
19	Correlation of Interleukin-6 levels and lectins during Schistosoma haematobium infection 2015 ·Cytokine ·Justin S. Antony, Olusola Ojurongbe, Christian G. Meyer, Kumarasamy Thangaraj, Anshuman Mishra, Peter G. Kremsner, Thirumalaisamy P. Velavan	8
20	IL-4 Haplotype -590T, -34T and Intron-3 VNTR R2 Is Associated with Reduced Malaria Risk among Ancestral Indian Tribal Populations 2012 ·PLoS ONE ·(unknown), (unknown), (unknown), Ashish Kumar Singh, Justin S. Antony, Hoang Văn Tong, Sakshi Singh, Sudhanshu S. Pati, Pradeep Kumar Patra, Singh Rajender, Nguyễn Lĩnh Toàn, Lê Hữu Song, (unknown), Iara Messias-Reason, Thirumalaisamy P. Velavan, Lalji Singh, Kumarasamy Thangaraj	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact